Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative factors that predict pathologic nodal involvement in early-stage HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant chemotherapy versus upfront surgery.
Faleh S, Prakash I, Salehi A, Khan H, Basik M, Boileau JF, Tejera D, Panet F, Martel K, Meterissian S, Wong SM. Faleh S, et al. Among authors: prakash i. Breast Cancer Res Treat. 2024 Jun;205(2):303-312. doi: 10.1007/s10549-024-07251-8. Epub 2024 Feb 21. Breast Cancer Res Treat. 2024. PMID: 38381275
Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment.
Wong SM, Apostolova C, Ferroum A, Alhassan B, Prakash I, Basik M, Martel K, Meterissian S, Fleiszer D, Wong N, Sadinsky MB, Malagon T, Boileau JF, Foulkes WD. Wong SM, et al. Among authors: prakash i. Hered Cancer Clin Pract. 2025 Apr 24;23(1):14. doi: 10.1186/s13053-025-00314-x. Hered Cancer Clin Pract. 2025. PMID: 40275390 Free PMC article.
Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
Wong SM, Ferroum A, Apostolova C, Alhassan B, Prakash I, Basik M, Boileau JF, Meterissian S, Aleynikova O, Wong N, Foulkes WD. Wong SM, et al. Among authors: prakash i. Ann Surg Oncol. 2022 Oct;29(11):6660-6668. doi: 10.1245/s10434-022-11916-3. Epub 2022 May 26. Ann Surg Oncol. 2022. PMID: 35616744
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study.
Montagna G, Alvarado M, Myers S, Mrdutt MM, Sun SX, Sevilimedu V, Barrio AV, van den Bruele AB, Boughey JC, Boyle MK, Crown A, Kesmodel SB, King TA, Kuerer HM, Leisha EC, Moo TA, Weiss A, Williams AD, Parmar P, Diskin B, Hlavin C, Diego EJ, Polidorio N, Abdelwahab K, Banys-Paluchowski M, Kurzeder C, Heidinger M, Goldschmidt M, Schulz A, Heil J, Karadeniz Cakmak G, Pislar N, Riis M, Prakash I, Ovalle V, Ugurlu MU, Franceschini G, Sergeevich EA, Morales J, Lee HB, Galimberti V, Ahn SG, Ryu JM, Muslumanoglu M, Cabıoğlu N, Yoo TR, Vrancken Peeters MJ, Ferrucci M, Morrow M, Weber WP; microNAC Study Group. Montagna G, et al. Among authors: prakash i. Lancet Oncol. 2026 Jan;27(1):57-67. doi: 10.1016/S1470-2045(25)00598-4. Lancet Oncol. 2026. PMID: 41449148 Free PMC article.
126 results